Literature DB >> 18221111

Resveratrol: a therapeutic promise for cardiovascular diseases.

Samarjit Das1, Dipak K Das.   

Abstract

The heart is an aerobic organ, and most of the energy required for the contraction and maintenance of ion gradients comes from oxidative phosphorylation. Oxidative stress caused by free radicals plays a crucial role in the pathophysiology associated with atherosclerosis, neoplasia and neurodegenerative diseases. Therefore, a great deal of attention has focused on the naturally occurring antioxidant phytochemicals as potential therapy for cardiovascular diseases. One of the most recognized and widely studied compounds is resveratrol, a member of a family of polyphenols called viniferins. Although resveratrol was first isolated in 1940 from the roots of white hellebore (Veratrum grandiflorum), the importance of resveratrol was recognized only after the widely publicized historic "French Paradox" associated with drinking of red wine. Both epidemiological and experimental studies have revealed that drinking wine, particularly red wine, in moderation protects cardiovascular health; however, the experimental basis for such an action is not fully understood. A growing body of evidence supports the role of resveratrol as evidence based cardiovascular medicine. Resveratrol protects the cardiovascular system by multidimensional way. The most important point about resveratrol is that at a very low concentration, it inhibits apoptotic cell death, thereby providing protection from various diseases including myocardial ischemic reperfusion injury, atherosclerosis and ventricular arrhythmias. Both in acute and in chronic models, resveratrol-mediated cardioprotection is achieved through the preconditioning effect (the state-of-the-art technique of cardioprotection), rather than direct effect as found in conventional medicine. The same resveratrol when used in higher doses, it facilitates apoptotic cell death, and behaves as a chemo-preventive alternative. Resveratrol likely fulfills the definition of a pharmacological preconditioning compound and gives hope for the therapeutic promise of alternative medicine. The purpose of this review is to provide evidence in favor of resveratrol to be used as a preventive medicine and related patents for the maintenance of healthy heart.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18221111     DOI: 10.2174/157489007780832560

Source DB:  PubMed          Journal:  Recent Pat Cardiovasc Drug Discov


  43 in total

Review 1.  Cancer stem cells: a novel paradigm for cancer prevention and treatment.

Authors:  Dharmalingam Subramaniam; Satish Ramalingam; Courtney W Houchen; Shrikant Anant
Journal:  Mini Rev Med Chem       Date:  2010-05       Impact factor: 3.862

2.  Resveratrol suppresses colitis and colon cancer associated with colitis.

Authors:  Xiangli Cui; Yu Jin; Anne B Hofseth; Edsel Pena; Joshua Habiger; Alexander Chumanevich; Deepak Poudyal; Mitzi Nagarkatti; Prakash S Nagarkatti; Udai P Singh; Lorne J Hofseth
Journal:  Cancer Prev Res (Phila)       Date:  2010-03-23

3.  Resveratrol blocks interleukin-18-EMMPRIN cross-regulation and smooth muscle cell migration.

Authors:  Balachandar Venkatesan; Anthony J Valente; Venkatapuram Seenu Reddy; Deborah A Siwik; Bysani Chandrasekar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-06-26       Impact factor: 4.733

4.  Preparation, characterization, and cellular uptake of resveratrol-loaded trimethyl chitosan nanoparticles.

Authors:  Jeong Bin Min; Eun Suh Kim; Ji-Soo Lee; Hyeon Gyu Lee
Journal:  Food Sci Biotechnol       Date:  2017-12-13       Impact factor: 2.391

Review 5.  MicroRNA signatures of resveratrol in the ischemic heart.

Authors:  Partha Mukhopadhyay; Pal Pacher; Dipak K Das
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

Review 6.  The progress of the research on cardio-vascular effects and acting mechanism of polydatin.

Authors:  Long-Tao Liu; Gang Guo; Min Wu; Wen-Gao Zhang
Journal:  Chin J Integr Med       Date:  2012-08-31       Impact factor: 1.978

Review 7.  Pharmacological modulation of cell death in atherosclerosis: a promising approach towards plaque stabilization?

Authors:  Wim Martinet; Dorien M Schrijvers; Guido R Y De Meyer
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

Review 8.  Resveratrol--pills to replace a healthy diet?

Authors:  Veronique S Chachay; Carl M J Kirkpatrick; Ingrid J Hickman; Maree Ferguson; Johannes B Prins; Jennifer H Martin
Journal:  Br J Clin Pharmacol       Date:  2011-07       Impact factor: 4.335

Review 9.  The biological responses to resveratrol and other polyphenols from alcoholic beverages.

Authors:  Lindsay Brown; Paul A Kroon; Dipak K Das; Samarjit Das; Arpad Tosaki; Vincent Chan; Manfred V Singer; Peter Feick
Journal:  Alcohol Clin Exp Res       Date:  2009-06-10       Impact factor: 3.455

10.  Resveratrol-loaded nanoparticles based on poly(epsilon-caprolactone) and poly(D,L-lactic-co-glycolic acid)-poly(ethylene glycol) blend for prostate cancer treatment.

Authors:  Vanna Sanna; Imtiaz Ahmad Siddiqui; Mario Sechi; Hasan Mukhtar
Journal:  Mol Pharm       Date:  2013-09-04       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.